Rafferty Asset Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 65,220 shares of ARCT stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

65,220

Previous 78,014 16.4%

Holding current value

$1.17 Million

Previous $1.9 Million 20.33%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$18.08 - $25.38 $231,315 - $324,711	-12,794 Reduced 16.4%	65,220 $1.51 Million
Q2 2024 Aug 13, 2024	SELL	$24.35 - $44.39 $1.91 Million - $3.49 Million	-78,579 Reduced 50.18%	78,014 $1.9 Million
Q1 2024 May 13, 2024	BUY	$31.23 - $42.99 $1.36 Million - $1.87 Million	43,421 Added 38.37%	156,593 $5.29 Million
Q4 2023 Feb 13, 2024	SELL	$17.71 - $32.97 $347,275 - $646,508	-19,609 Reduced 14.77%	113,172 $3.57 Million
Q3 2023 Nov 13, 2023	SELL	$25.44 - $37.35 $653,909 - $960,044	-25,704 Reduced 16.22%	132,781 $3.39 Million
Q2 2023 Aug 11, 2023	SELL	$23.94 - $32.36 $1.15 Million - $1.55 Million	-47,989 Reduced 23.24%	158,485 $4.55 Million
Q1 2023 May 11, 2023	SELL	$14.72 - $23.97 $40,921 - $66,636	-2,780 Reduced 1.33%	206,474 $4.95 Million
Q4 2022 Feb 13, 2023	SELL	$14.14 - $23.06 $731,405 - $1.19 Million	-51,726 Reduced 19.82%	209,254 $3.55 Million
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $793,361 - $1.35 Million	60,794 Added 30.37%	260,980 $3.87 Million
Q2 2022 Aug 12, 2022	SELL	$12.26 - $31.17 $1.25 Million - $3.18 Million	-102,004 Reduced 33.75%	200,186 $3.15 Million
Q1 2022 May 13, 2022	BUY	$17.64 - $39.57 $1.44 Million - $3.24 Million	81,784 Added 37.11%	302,190 $8.15 Million
Q4 2021 Feb 10, 2022	BUY	$34.2 - $47.56 $2.1 Million - $2.93 Million	61,523 Added 38.72%	220,406 $8.16 Million
Q3 2021 Nov 10, 2021	SELL	$27.88 - $58.25 $779,134 - $1.63 Million	-27,946 Reduced 14.96%	158,883 $7.59 Million
Q2 2021 Aug 10, 2021	BUY	$25.79 - $42.11 $3.08 Million - $5.03 Million	119,483 Added 177.42%	186,829 $6.32 Million
Q1 2021 May 10, 2021	BUY	$38.75 - $86.92 $2.27 Million - $5.09 Million	58,551 Added 665.73%	67,346 $2.78 Million
Q4 2020 Feb 10, 2021	SELL	$34.61 - $123.66 $1.47 Million - $5.27 Million	-42,609 Reduced 82.89%	8,795 $382,000
Q3 2020 Nov 13, 2020	BUY	$37.49 - $63.19 $1.93 Million - $3.25 Million	51,404 New	51,404 $2.21 Million

Others Institutions Holding ARCT

# of Institutions

178

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $478M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History